Pitfalls in Urine Cytology: A Case of Fumarate Hydratase‐Deficient Renal Cell Carcinoma Initially Diagnosed as High‐Grade Urothelial Carcinoma

Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare, aggressive, hereditary subtype of renal cancer that requires careful diagnostic considerations. We report a case of a 33-year-old Asian woman who presented with a 20-day history of hematuria. Imaging studies revealed a solid tumor in the lower pole of the right kidney with lymph node metastases. Urinary cytology revealed benign squamous cells, inflammatory cells, and atypical epithelial cells, suggestive of high-grade urothelial carcinoma. Following a right nephrectomy, the tumor displayed papillary structures composed of cells exhibiting atypical, elongated nuclei with eosinophilic nucleoli and peripheral halos. Immunohistochemical staining demonstrated negative FH expression. Genetic analysis identified a somatic missense mutation in the FH gene, confirming the diagnosis of FH-deficient RCC. This case highlights the importance of integrating cytological, histological, and genetic analyses for accurate diagnosis of FH-deficient RCC.

Authors

Institutions

Publication Details

Journal
Diagnostic Cytopathology
Published
2024-10-11
DOI
https://doi.org/10.1002/dc.25409
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pitfalls in Urine Cytology: A Case of Fumarate Hydratase‐Deficient Renal Cell Carcinoma Initially Diagnosed as High‐Grade Urothelial Carcinoma

Qiu Rao, Kai Cheng, Wei Bao, Xuelian Zhang et al.
1 citations
Diagnostic Cytopathology
Renal cell carcinoma treatment
0.42
article

Pitfalls in Urine Cytology: A Case of Fumarate Hydratase‐Deficient Renal Cell Carcinoma Initially Diagnosed as High‐Grade Urothelial Carcinoma

Qiu Rao, Kai Cheng, Wei Bao, Xuelian Zhang, Xiaodie Zhou, Xiaotong Wang
article en
1 citations

Abstract

Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare, aggressive, hereditary subtype of renal cancer that requires careful diagnostic considerations. We report a case of a 33-year-old Asian woman who presented with a 20-day history of hematuria. Imaging studies revealed a solid tumor in the lower pole of the right kidney with lymph node metastases. Urinary cytology revealed benign squamous cells, inflammatory cells, and atypical epithelial cells, suggestive of high-grade urothelial carcinoma. Following a right nephrectomy, the tumor displayed papillary structures composed of cells exhibiting atypical, elongated nuclei with eosinophilic nucleoli and peripheral halos. Immunohistochemical staining demonstrated negative FH expression. Genetic analysis identified a somatic missense mutation in the FH gene, confirming the diagnosis of FH-deficient RCC. This case highlights the importance of integrating cytological, histological, and genetic analyses for accurate diagnosis of FH-deficient RCC.

Diagnostic CytopathologyVol. 53(1)
Nanjing General Hospital of Nanjing Military Command (CN), Kingmed Diagnostics (CN), Nanjing University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 32%
Renal cell carcinoma treatment
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.